Enfoque inicial del paciente con hemorragia alveolar difusa sin vasculitis pulmonar
Initial workup of the patient with diffuse alveolar hemorrhage without pulmonary vasculitis
Contenido principal del artículo
Resumen
Palabras clave:
Descargas
Detalles del artículo
Referencias (VER)
Specks U. Diffuse alveolar hemorrhage syndromes. Current Opinion in Rheumatology 2001; 13 (1): 12-17.
Ioachimescu OC, Stoller JK. Diffuse alveolar hemorrhage: diagnosing it and finding the cause. Cleve Clin J Med 2008; 75 (4): 258: 260-265.
Lara AR, Schwarz MI. Diffuse alveolar hemorrhage. Chest 2010; 137 (5): 1164-7.
Newsome, Brandi R. Diffuse alveolar hemorrhage. Southern Medical Journal 2011; 104 (4): 269-274.
McCabe C, Jones Q, Nikolopoulou A. Pulmonary-renal syndromes: An update for respiratory physicians. Respir Med 2011 Jun 17. [Epub ahead of print].
Jara LJ, Vera-Lastra O, Calleja MC. Pulmonary-renal vasculitic disorders: differential diagnosis and management. Curr Rheumatol Rep 2003; 5 (2): 107-15.
Hellmich B, Gross WL. Diffi cult to diagnose manifestations of vasculitis: does an interdisciplinary approach help? Best Pract Res Clin Rheumatol 2005; 19 (2): 243-61.
Cordier JF, Cottin V. Alveolar hemorrhage in vasculitis: primary and secondary. Semin Respir Crit Care Med 2011; 32 (3): 310-21.
Willms H, Gutjahr K. Diagnostics and therapy of idiopathic pulmonary hemosiderosis. Med Klin (Munich) 2007; 102 (6): 445-50.
Oviedo Ramírez MI, Hop K, Carrera E, Soriano Rosas J. Idiopathic pulmonary haemosiderosis in a young adult. Autopsy findings Arch Bronconeumol 2010; 46 (10): 565-7. Epub 2010.Aug 13.
Chen CH, Yang HB, Chiang SR, Wang PC. Idiopathic pulmonary hemosiderosis: favorable response to corticosteroids. J Chin Med Assoc 2008; 71 (8): 421-4.
Chermiti BA Fatma, Chtourou A, Mahouchi R. Idiopathic pulmonary hemosiderosis in adult. Respiratory Medicine CME 2010; 3 (4): 238-240.
Ioachimescu O. Idiopathic pulmonary hemosiderosis in adults. Clinical Pulmonary Medicine 2005; 12 (1): 16-25.
Dolan CJ Jr, Srodes CH, Duffy FD. Idiopathic pulmonary hemosiderosis: electron microscopic, immunofl uorescent, and iron kinetic studies. Chest 1975; 68: 577-580.
Corrin B, Jagusch M, Dewar A, et al. Fine structural changes in idiopathic pulmonary haemosiderosis. J Pathol 1987; 153: 249-256.
Irwin RS, Cottrell TS, Hsu KC, et al. Idiopathic pulmonary hemosiderosis: an electron microscopic and immunofl uorescent study. Chest 1974; 65: 41-45.
Blanco A, Solis P, Gómez S, et al. C1q-binding immune complexes and other immunological studies in children with pulmonary hemosiderosis. Allergol Immunopathol (Madr) 1984; 12: 37-44.
Fullmer JJ, Langston C. Pulmonary capillaritis in children: a review of eight cases with comparison to other alveolar hemorrhage syndromes The Journal of Pediatrics 2005; 146 (3): 376-38.
Le Clainche L, Le Bourgeois M, Fauroux B, et al. Long-term outcome of idiopathic pulmonary hemosiderosis in children. Medicine (Baltimore). 2000; 79: 318-326.
Mayes DH, Guerrero ML A few good men: a Marine with hemoptysis and diarrhea. Idiopathic pulmonary hemosiderosis and celiac sprue. Chest 2008; 134 (3): 644-7.
Khemiri M, Ouederni M. Screening for celiac disease in idiopathic pulmonary hemosiderosis. Gastroenterol Clin Biol 2008; 32 (8-9): 745-8.
Centers for Disease Control and Prevention. Update: pulmonary hemorrhage/hemosiderosis among infants: Cleveland, Ohio, 1993–1996. JAMA 2000; 283: 1951-1953.
Rao NR, Goodman LR. Smoking-related interstitial lung disease. Annals of Diagnostic Pathology 2008; 12 (6): 445-457.
Deniz O, Ongürü O. Idiopathic pulmonary hemosiderosis in an adult patient responded well to corticosteroid therapy. Tuberk Toraks 2007; 55 (1): 77-82.
Nuesslein TG, Teig N. Pulmonary haemosiderosis in infants and children. Paediatric Respiratory Reviews 2006; 7 (1): 45-48.
Olser W. On the visceral manifestations of the erythema group of skin diseases. Am J Med Sci 2009; 338 (5): 396-408.
Santos Ocampo AS, Mandell BF, Fessler BJ. Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest 2000; 118 (4): 1083-90.
Badsha H, et al. Pulmonary hemorrhage in systemic lupus erythematosus. Seminars in Arthritis and Rheumatism 2004; 33 (6): 414-42.
Pego-Reigosa JM, Medeiros DA. Respiratory manifestations of systemic lupus erythematosus: old and new concepts. Best Practice & Research Clinical Rheumatology 2009; 23 (4): 469-480.
Gómez-Román JJ. Diffuse alveolar hemorrhage. Archivos de Bronconeumología (English Edition). 2008; 44 (8): 428-436.
Mahmoud GA, Gheith RE. Alveolar hemorrhage in systemic lupus erythematosus: An overview. The Egyptian Rheumatologist 2011; 33 (1): 1-1.
O’Hara, Collin, Song, Joo Young. Goodpasture’s syndrome with negative serology. Pathology Case Reviews 2007; 12 (3): 109-112.
Brandi R. Diffuse alveolar hemorrhage. Southern Medical Journal 2011; 104 (4): 269-274.
Lê Quang C, Delèvaux I. Intra-alveolar haemorrhage without renal damage as the initial presenting feature of Goodpasture’s syndrome: case report and review of literature. Rev Med Interne 2008; 29 (12): 1038-42. Epub 2008 Jun 24.
Cui Z, Zhao J, Jia XY. Clinical features and outcomes of antiglomerular basement membrane disease in older patients. Am J Kidney Dis 2011; 57 (4): 575-82. Epub 2010 Dec 18.
Shah MK, Hugghins SY. Characteristics and outcomes of patients with Goodpasture’s syndrome. South Med J 2002; 95 (12): 1411-8.
Tomashefski JF Jr. Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med 2000; 21 (3): 435-466.
Huppmann AR. Drug-induced lung disease. Pathology Case Reviews 2007; 12 (3): 113-117.
Castro CY. ARDS and diffuse alveolar damage: a pathologist’s perspective. Semin Thorac Cardiovasc Surg 2006; 18 (1): 13-9.
Case JP. Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs. Am J Ther 2001; 8 (2): 123-43.
Ishida K, Seki R. Clinical aspect of diffuse alveolar hemorrhage syndrome. Nihon Kokyuki Gakkai Zasshi 2003; 41 (12): 851-6.
Cohen S. Diffuse pulmonary hemorrhage: evolutionary ‘flaw’ or consequence of evolutionary progress? Am J Med Sci 2002; 323 (3): 130-9.
O’Callaghan DS, Dorfmuller P. Pulmonary veno-occlusive disease: the bête noire of pulmonary hypertension in connective tissue diseases? Presse Med 2011; 40 (1 Pt 2): e65-78. Epub 2011 Jan 5.
Barboza CE, Jardim CV. Pulmonary veno-occlusive disease: diagnostic and therapeutic alternatives. J Bras Pneumol 2008; 34 (9): 749-52.
Lantuéjoul S, Sheppard MN. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. Am J Surg Pathol 2006; 30 (7): 850-7.
Montani D, O’Callaghan DS, Pulmonary veno-occlusive disease: recent progress and current challenges. Respir Med 2010; 104 (Suppl. 1): S23-32. Epub 2010 Apr 24.
Sullivan A, Chmura K Pulmonary capillary hemangiomatosis: an immunohistochemical analysis of vascular remodeling. Eur J Med Res 2006; 11 (5): 187-93.
Almagro P, Julià J. Pulmonary capillary hemangiomatosis associated with primary pulmonary hypertension: report of 2 new cases and review of 35 cases from the literatura. Medicine (Baltimore) 2002; 81 (6): 417-24.
Kothari S. Pulmonary capillary hemangiomatosis. Circulation 2009; 120 (4): 352-354.
Pacheco-Rodríguez G, Moss J. The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells. Crit Rev Immunol 2010; 30 (4): 387-94.
Ansótegui Barrera E, Mancheño Franch N. Lymphangioleiomyomatosis. Archivos de Bronconeumología (English Edition) 2011; 47 (2): 85-93.
Gao J, Zhu P. A clinicopathological analysis of pulmonary lymphangioleiomyomatosis. Zhongguo Fei Ai Za Zhi 2011; 14 (4): 378-82.
Glasgow CG, Steagall WK. Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies. Respir Med 2010; 104 (Suppl. 1): S45-58.
Díaz J, Calamia KT, Lee AS. Pulmonary vasculitis in the intensive care unit. J Intensive Care Med 2011; 26 (2): 88-104.